Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings (Accumulated Deficit)	Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2022		133,236,687
Beginning balance at Dec. 31, 2022	$ 2,077,963	$ 13	$ 1,709,835	$ (9,122)	$ 377,237	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		734,662
Exercise of stock options (in shares)		487,014
Exercise of stock options	3,484		3,484
Issuance of common stock under employee stock purchase plan (in shares)		322,923
Issuance of common stock under employee stock purchase plan	4,283		4,283
Stock-based compensation	111,316		111,316
Other comprehensive income (loss)	8,307			8,307
Contributions from noncontrolling owners	100					100
Increase in ownership interest in a subsidiary	(100)		(56)			(44)
Net loss	(615,117)				(615,061)	(56)
Ending balance (in shares) at Dec. 31, 2023		134,781,286
Ending balance at Dec. 31, 2023	1,590,236	$ 13	1,828,862	(815)	(237,824)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		1,368,362
Vesting of restricted common stock	1	$ 1
Exercise of stock options (in shares)		322,366
Exercise of stock options	790		790
Issuance of common stock under employee stock purchase plan (in shares)		487,432
Issuance of common stock under employee stock purchase plan	3,763		3,763
Stock-based compensation	78,457		78,457
Other comprehensive income (loss)	(902)			(902)
Net loss	$ (521,960)				(521,960)	0
Ending balance (in shares) at Dec. 31, 2024	136,959,446	136,959,446
Ending balance at Dec. 31, 2024	$ 1,150,385	$ 14	1,911,872	(1,717)	(759,784)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted common stock (in shares)		1,571,496
Vesting of restricted common stock	0
Exercise of stock options (in shares)		298,260
Exercise of stock options	1,349		1,349
Issuance of common stock under employee stock purchase plan (in shares)		645,752
Issuance of common stock under employee stock purchase plan	2,797		2,797
Stock-based compensation	49,072		49,072
Other comprehensive income (loss)	(340)			(340)
Net loss	$ (437,987)				(437,987)	0
Ending balance (in shares) at Dec. 31, 2025	139,474,954	139,474,954
Ending balance at Dec. 31, 2025	$ 765,276	$ 14	$ 1,965,090	$ (2,057)	$ (1,197,771)	$ 0